[ACRX] QoQ Quarter Result on 31-Mar-2021 [#Q1]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
17-May-2021
Financial Year
2021
Quarter
31-Mar-2021 [#Q1]
Profit Trend
QoQ- -0.43%
YoY- 43.76%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Revenue 2 1,862 443 511 738 1,368 2,924 -99.21%
PBT -7,917 -8,375 -9,846 -8,956 -8,918 -8,930 -6,602 12.83%
Tax 467 796 5 858 698 931 4 2268.13%
NP -7,917 -8,375 -9,851 -8,956 -8,918 -8,930 -6,606 12.79%
Tax Rate - - - - - - - -
Total Cost 7,919 10,237 10,294 9,467 9,656 10,298 9,530 -11.58%
Ratio Analysis
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
NP Margin -395,850.00 -449.79 -2,223.70 -1,752.64 -1,208.40 -652.78 -225.92 14237.57%
Per Share
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
EPS -1.24 -1.40 -1.65 -1.58 -1.93 -2.03 -1.64 -16.96%
EPS Diluted -1.24 -1.40 -1.65 -1.58 -1.93 -2.03 -1.64 -16.96%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.